7/15/2022China's Community Health Centers Are Losing Public Appeal

7/15/2022Chinese Leaders Pledge to Advance Reform and Reduce Public Healthca...

7/15/2022Recent Official and Executive Moves

7/15/2022Drug R&D and Product Registration News Digest July 2022 (2)

7/14/2022FDA Defers Action on BeiGene/Novartis's Tislelizumab for Esophagus Can...

7/14/2022CStone Considers Sale Amid Mounting Challenges: Bloomberg

7/14/2022China's Latest Round of Volume-Based Procurement of Drugs Further Redu...

7/14/2022Chinese Biopharma In-licensing Deals in H1/2022 (Pharmcube)

7/14/2022China's Budding Drug Innovation Shows Signs of Life Despite Biotech Wi...

7/13/2022Chinese Drugmakers Set Sights on Emerging Markets (PharmaDJ)

7/13/2022Chinese Biopharma Out-licensing Deals in H1/2022 (Pharmcube)

7/13/2022CDE Solicits Comments on the Draft Technical Guidelines for Safety Eva...

7/13/2022Korea's Orion Holdings Agrees to Build A Tuberculosis Vaccine Plant in...

7/12/2022Review of Chinese New Drugs Approvals in H1/2022

7/12/2022JPO Publicizes 7th VBP Tender Outcome, Which Slashes Average Prices by...

7/12/2022China on the Move: Proposed Pharmaceutical Regulations Would Comprehen...

7/12/2022AstraZeneca, Pfizer, Novartis and More Lose Out in China's Latest Roun...

7/12/2022Youtube Video: Layoff Triggered in China's Pharma as Beijing Continues...

7/11/2022NMPA Announces OTC Switch of Potassium Glucosamine Sulfate Tablets

7/11/2022Tasly Pharma and Mauna Kea Tech Announce JV and Licensing Pact

7/8/2022Chinese Government Issues New Document to Secure Urban/Rural Resident ...

7/8/2022Sinopharm Explores $1 Billion Deal for BBI Life Sciences

7/8/2022Drug R&D and Product Registration News Digest July 2022 (1)

7/8/2022Brii Exercises Option for Vir Bio's mAb VIR-3434 in Greater China

7/8/2022Asia's Rise in The Global Pharma Industry (PharmExec)

7/7/2022Chinese Drugmakers Scramble to Get a Headstart in GLP-1R Race (PharmaD...

7/7/2022BeiGene's R&D Chief Knows PD-1 Is Crowded. But TIGIT, Combos and a Nov...

7/7/2022CDE Solicits Comments on the Draft Working Procedures for Triggered In...

7/7/2022CDE Solicits Comments on the Draft Technical Guidelines for Pharmaceut...

7/7/2022CDE Solicits Comments on the Draft Guidelines for Design and Protocol ...

Page:78/719 Total number of articles:21546: [First][<<] [76] [77] [78] [79] [80] [>>] [End]